[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

E-DRUG: Resolution Internet Promotion

     This post concerns Internet marketing of pharmaceutical drugs, one of
  the emerging issues of Internet commerce.  Jamie
  ---------- Forwarded message ----------
  Date: Thu, 3 Jul 1997 03:07:01 -0400
  From: Wemos <Wemos@tip.nl>
  Reply-To: e-drug@usa.healthnet.org
  To: E-DRUG Mailing List <E-Drug@usa.healthnet.org>
  Subject: E-DRUG: Resolution Internet Promotion
  E-DRUG: Resolution Internet Promotion (cont)
  Dear e-druggers,
  The WHA-resolution (number 50.4) on 'Cross-border advertising,
  promotion and sale of medical products through the Internet' from
  May, 12, 1997, can be found at:
  The WHO will organize a conference on this subject of Internet
  advertising in September this year.
  Here's the full text of the resolution:
  Agenda item 1912 May 1997
                   Cross-border advertising, promotion and sale
                     of medical products through the Internet
     The Fiftieth World Health Assembly,
     Aware of the increasing use of electronic communication means
  by the general public for shopping and gathering information;
     Aware of the fact that the efficacy, safety and quality of
  medical products require careful assessment, and that in many
  Member States such products require authorization prior to
  marketing, and are available only on medical prescription;
     Aware that the proper and safe use of medical products may
  require review of the medical history, medical examination,
  diagnosis of the condition and subsequent counselling and
  follow-up by the health care professional;
     Recognizing that regulations and regulatory control vary among
  countries regarding prescription/non- prescription
  (over-the-counter) status of medical products, resulting in
  national differences in their availability;
     Aware that advertising, promotion and legal sale of medical
  products in one country may be violative in other countries;
     Recognizing that in some situations provision of medical
  products by an authorized health professional on the basis of an
  electronically communicated request may contribute to more
  rational and better health care, and to the easier availability
  of necessary medical products and information about them;
     Recognizing that such mail order service may in some countries
  include prescription-only products, and that in such situations
  national law may specify additional requirements to authorize the
     Noting the continued need for vigilance in the maintenance of
  legal and ethical standards in the advertising, promotion and
  sale of medical products;
     Concerned, however, that uncontrolled advertising, promotion
  and sales of medical products by electronic communication may
  present a hazard for public health as well as a risk for the
  individual patient, particularly with regard to misleading or
  fraudulent product information and lack of individual
     Particularly concerned that advertising, promotion and sales
  through the Internet may lead to uncontrolled across-the-border
  trade of medical products or fraudulent imitations that may be
  unevaluated, unapproved, unsafe or ineffective, or used
  1.URGES all Member States to collaborate with WHO in order to
  facilitate collection of information on the Internet regarding
  the points listed above;
  2.REQUESTS the Director-General:
     (1)to collect information on the various aspects and
  consequences of advertising, promotion, and sale of medical
  products through the Internet;
     (2)to collaborate with the drug regulatory authorities and
  national and international enforcement agencies, consumer groups,
  professional associations, the pharmaceutical industry and other
  relevant parties, to collect all necessary information on the
     (3)to convene a WHO ad hoc working group consisting of
  representatives of the parties mentioned above, and, in addition,
  experts in ethics, legal matters, marketing and communication,
  and other experts as required, to consider and review the above
  and related issues in the advertising, promotion and sale of
  medical products through the Internet, and to formulate
  recommendations for action to the Director- General;
     (4)to report on progress to the Executive Board at its 101st
  session in January 1998, and to the Fifty- first World Health
  Assembly in May 1998;
     (5)to mobilize extrabudgetary resources for this activity.
     Eighth plenary meeting, 12 May 1997
     A50/VR/8 =
  The European Commission directives forbid direct-to-the-public
  sale of prescription medicines (92/28/EEC and 92/26/EEC). The
  problem with Internet advertising however is it cross-border
  character and difficulties in tracing owners of home-pages, hence
  in this case drug-providers. In the European Union the agenda of
  the pharmaceutical committee already has an item on Internet
  advertising: It is considered that Internet Providers should be
  made responsible for the information they provide. Strict
  surveillance of distribution channels of medicines
  is seen as the best way to tackle this problem. =
  Can anyone comment this? I'm also interested in case-material
  (Internet-addresses where medicines can be ordered).
  Mark Raijmakers
  -- =
  The Wemos Foundation is a Dutch non-profit organisation =
  that addresses international health issues through policy =
  advocacy and education activities. =
            Wemos Foundation
  (ADR)     P.O. Box 1693
            1000 BR Amsterdam
            The Netherlands
  (TEL)     +31-20-420.22.22
  (FAX)     +31-20-620.50.94
  (EMA)     wemos@tip.nl (NEW address since April 1, 1997)
  (WWW)     http://www.antenna.nl/wemos (under construction)
  Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
  Mail administrative requests to `majordomo@usa.healthnet.org'.
  For additional assistance, send mail to:  `owner-e-drug@usa.healthnet.org'.